CUSIP NO. 31189P102                           13G                            Page 1 of 15

                                                                              UNITED STATES
                                                         SECURITIES AND EXCHANGE COMMISSION
                                                                     Washington, D.C. 20549
 
                                                                             SCHEDULE 13G
 
                                                Under the Securities Exchange Act of 1934
                                                                       (Amendment No. 1)*
 
                                                                  FATE THERAPEUTICS, INC.
                                                                         (Name of Issuer)
 
                                                           Common Stock, $0.001 par value
                                                           (Title of Class of Securities)
 
                                                                                31189P102 
                                                                           (CUSIP Number)
 
                                                                        December 31, 2016
 
                                  (Date of Event Which Requires Filing of this Statement)
 
   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
   [X] Rule 13d‑1(b)
   [ ] Rule 13d‑1(c)
   [ ] Rule 13d‑1(d)
 
   *The remainder of this cover page shall be filled out for a reporting person's initial
   filing on this form with respect to the subject class of securities, and for any
   subsequent amendment containing information which would alter the disclosures provided in
   a prior cover page.
 
   The information required in the remainder of this cover page shall not be deemed to be
   "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or
   otherwise subject to the liabilities of that section of the Act but shall be subject to
   all other provisions of the Act (however, see the Notes).

   

     CUSIP NO. 31189P102                           13G                            Page 2 of 15

         1.    NAMES OF REPORTING PERSONS.    
 
                     Franklin Resources, Inc.
 
         2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
                     (a) 
                     (b) X
 
         3.    SEC USE ONLY
 
         4.    CITIZENSHIP OR PLACE OF ORGANIZATION
 
                     Delaware 
 
         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
         5.    SOLE VOTING POWER
 
                     (See Item 4)
 
         6.    SHARED VOTING POWER
 
                     (See Item 4)
 
         7.    SOLE DISPOSITIVE POWER
 
                     (See Item 4)
 
         8.    SHARED DISPOSITIVE POWER
 
                     (See Item 4)
 
         9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
                     6,076,879 
 
         10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
                     CERTAIN SHARES [ ]
 
         11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
                     14.7% 
 
         12.   TYPE OF REPORTING PERSON
 
                     HC, CO (See Item 4)

   

     CUSIP NO. 31189P102                           13G                            Page 3 of 15

         1.    NAMES OF REPORTING PERSONS.    
 
                     Charles B. Johnson
 
         2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
                     (a) 
                     (b) X
 
         3.    SEC USE ONLY
 
         4.    CITIZENSHIP OR PLACE OF ORGANIZATION
 
                     USA 
 
         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
         5.    SOLE VOTING POWER
 
                     (See Item 4)
 
         6.    SHARED VOTING POWER
 
                     (See Item 4)
 
         7.    SOLE DISPOSITIVE POWER
 
                     (See Item 4)
 
         8.    SHARED DISPOSITIVE POWER
 
                     (See Item 4)
 
         9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
                     6,076,879 
 
         10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
                     CERTAIN SHARES [ ]
 
         11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
                     14.7% 
 
         12.   TYPE OF REPORTING PERSON
 
                     HC, IN (See Item 4)

   

     CUSIP NO. 31189P102                           13G                            Page 4 of 15

         1.    NAMES OF REPORTING PERSONS.    
 
                     Rupert H. Johnson, Jr.
 
         2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
                     (a) 
                     (b) X
 
         3.    SEC USE ONLY
 
         4.    CITIZENSHIP OR PLACE OF ORGANIZATION
 
                     USA 
 
         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
         5.    SOLE VOTING POWER
 
                     (See Item 4)
 
         6.    SHARED VOTING POWER
 
                     (See Item 4)
 
         7.    SOLE DISPOSITIVE POWER
 
                     (See Item 4)
 
         8.    SHARED DISPOSITIVE POWER
 
                     (See Item 4)
 
         9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
                     6,076,879 
 
         10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
                     CERTAIN SHARES [ ]
 
         11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
                     14.7% 
 
         12.   TYPE OF REPORTING PERSON
 
                     HC, IN (See Item 4)

   

     CUSIP NO. 31189P102                           13G                            Page 5 of 15

         1.    NAMES OF REPORTING PERSONS.    
 
                     Franklin Advisers, Inc.
 
         2.    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
                     (a) 
                     (b) X
 
         3.    SEC USE ONLY
 
         4.    CITIZENSHIP OR PLACE OF ORGANIZATION
 
                     California 
 
         NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
 
         5.    SOLE VOTING POWER
 
                     6,076,879  
 
         6.    SHARED VOTING POWER
 
                     0 
 
         7.    SOLE DISPOSITIVE POWER
 
                     6,076,879  
 
         8.    SHARED DISPOSITIVE POWER
 
                     0 
 
         9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
                     6,076,879 
 
         10.   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
                     CERTAIN SHARES [ ]
 
         11.   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
                     14.7% 
 
         12.   TYPE OF REPORTING PERSON
 
                     IA, CO (See Item 4)

   

     CUSIP NO. 31189P102                           13G                            Page 6 of 15

         Item 1.
 
         (a)   Name of Issuer
 
                     FATE THERAPEUTICS, INC.
 
         (b)   Address of Issuer's Principal Executive Offices
 
           3535 General Atomics Court, Suite 200
           San Diego, CA 92121
 
         Item 2.
 
         (a)   Name of Person Filing
                     (i):   Franklin Resources, Inc.
 
                     (ii):  Charles B. Johnson
 
                     (iii): Rupert H. Johnson, Jr.
 
                     (iv):  Franklin Advisers, Inc.

         (b)   Address of Principal Business Office or, if none, Residence
 
                     (i), (ii), and (iii):
                                 One Franklin Parkway
                                 San Mateo, CA 94403‑1906
                    (iv): One Franklin Parkway
                                 San Mateo, CA  94403‑1906
 
         (c)   Citizenship
 
                     (i):     Delaware
 
                     (ii) and (iii): USA
 
                     (iv): California

         (d)   Title of Class of Securities
 
                     Common Stock, $0.001 par value
 
         (e)   CUSIP Number
 
                     31189P102 

   

     CUSIP NO. 31189P102                           13G                            Page 7 of 15

       Item 3. If this statement is filed pursuant to §§240.13d‑1(b) or 240.13d‑2(b) or (c),
                       check whether the person filing is a:
                     (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
 
                     (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
                     (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C.
                                     78c). 
 
                     (d) [ ] Investment company registered under section 8 of the Investment Company
                                     Act of 1940 (15 U.S.C 80a‑8).
 
                     (e) [X] An investment adviser in accordance with §240.13d‑1(b)(1)(ii)(E);
 
                     (f) [ ] An employee benefit plan or endowment fund in accordance with
                                     §240.13d‑1(b)(1)(ii)(F); 
 
                     (g) [X] A parent holding company or control person in accordance with
                                     §240.13d‑1(b)(1)(ii)(G); 
 
                     (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit
                                     Insurance Act (12 U.S.C. 1813);
 
                     (i) [ ] A church plan that is excluded from the definition of an investment
                                     company under section 3(c)(14) of the Investment Company Act of 1940 (15
                                     U.S.C. 80a‑3);
 
                     (j) [ ] A non‑U.S. institution in accordance with §240.13d‑1(b)(ii)(J);
 
                     (k) [ ] Group, in accordance with §240.13d 1(b)(1)(ii)(K).
 
                     If filing as a non‑U.S. institution in accordance with §240.13d‑1(b)(1)(ii) (J).
                     please specify the type of institution:
 
         Item 4.  Ownership
 
         The securities reported herein are beneficially owned by one or more open‑ or
         closed‑end investment companies or other managed accounts that are investment
         management clients of investment managers that are direct and indirect subsidiaries
         (each, an “Investment Management Subsidiary” and, collectively, the “Investment
         Management Subsidiaries”) of Franklin Resources Inc. (“FRI”), including the Investment
         Management Subsidiaries listed in this Item 4.  When an investment management contract
         (including a sub‑advisory agreement) delegates to an Investment Management Subsidiary
         investment discretion or voting power over the securities held in the investment
         advisory accounts that are subject to that agreement, FRI treats the Investment
         Management Subsidiary as having sole investment discretion or voting authority, as the
         case may be, unless the agreement specifies otherwise. Accordingly, each Investment
         Management Subsidiary reports on Schedule 13G that it has sole investment discretion
         and voting authority over the securities covered by any such investment management
         agreement, unless otherwise noted in this Item 4.  As a result, for purposes of Rule
         13d‑3 under the Act, the Investment Management Subsidiaries listed in this Item 4 may
         be deemed to be the beneficial owners of the securities reported in this Schedule 13G.

   

     CUSIP NO. 31189P102                           13G                            Page 8 of 15
 
         Beneficial ownership by Investment Management Subsidiaries and other FRI affiliates is
         being reported in conformity with the guidelines articulated by the SEC staff in
         Release No. 34‑39538 (January 12, 1998) relating to organizations, such as FRI, where
         related entities exercise voting and investment powers over the securities being
         reported independently from each other.  The voting and investment powers held by
         Franklin Mutual Advisers, LLC (“FMA”), an indirect wholly‑owned Investment Management
         Subsidiary, are exercised independently from FRI and from all other Investment
         Management Subsidiaries (FRI, its affiliates and the Investment Management
         Subsidiaries other than FMA are collectively, “FRI affiliates”). Furthermore, internal
         policies and procedures of FMA and FRI establish informational barriers that prevent
         the flow between FMA and the FRI affiliates of information that relates to the voting
         and investment powers over the securities owned by their respective management
         clients. Consequently, FMA and FRI affiliates report the securities over which they
         hold investment and voting power separately from each other for purposes of Section 13
         of the Act.
 
         Charles B. Johnson and Rupert H. Johnson, Jr. (the “Principal Shareholders”) each own
         in excess of 10% of the outstanding common stock of FRI and are the principal
         stockholders of FRI.  FRI and the Principal Shareholders may be deemed to be, for
         purposes of Rule 13d‑3 under the Act, the beneficial owners of securities held by
         persons and entities for whom or for which FRI subsidiaries provide investment
         management services.  The number of shares that may be deemed to be beneficially owned
         and the percentage of the class of which such shares are a part are reported in Items
         9 and 11 of the cover pages for FRI and each of the Principal Shareholders.  FRI, the
         Principal Shareholders and each of the Investment Management Subsidiaries disclaim any
         pecuniary interest in any of the such securities.  In addition, the filing of this
         Schedule 13G on behalf of the Principal Shareholders, FRI and the FRI affiliates, as
         applicable, should not be construed as an admission that any of them is, and each of
         them disclaims that it is, the beneficial owner, as defined in Rule 13d‑3, of any of
         the securities reported in this Schedule 13G.
 
         FRI, the Principal Shareholders, and each of the Investment Management Subsidiaries
         believe that they are not a “group” within the meaning of Rule 13d‑5 under the Act and
         that they are not otherwise required to attribute to each other the beneficial
         ownership of the securities held by any of them or by any persons or entities for whom
         or for which the Investment Management Subsidiaries provide investment management
         services. 
 
                     (a)   Amount beneficially owned:
 
                                 6,076,879 
 
                     (b)   Percent of class:
 
                                 14.7% 
 
                     (c)   Number of shares as to which the person has:
 
                             (i)  Sole power to vote or to direct the vote
 
                                       Franklin Resources, Inc.:                                            0
 
                                       Charles B. Johnson:                                                  0
 
                                       Rupert H. Johnson, Jr.:                                              0
 
                                       Franklin Advisers, Inc.:                                     6,076,879
 
                           (ii)  Shared power to vote or to direct the vote
 
                                       0 

   

     CUSIP NO. 31189P102                           13G                            Page 9 of 15

                         (iii)  Sole power to dispose or to direct the disposition of
 
                                       Franklin Resources, Inc.:                                            0
 
                                       Charles B. Johnson:                                                  0
 
                                       Rupert H. Johnson, Jr.:                                              0
 
                                       Franklin Advisers, Inc.:                                     6,076,879
 
                          (iv)   Shared power to dispose or to direct the disposition of
 
                                       0 
 
         Item 5.  Ownership of Five Percent or Less of a Class
 
                           If this statement is being filed to report the fact that as of the date
                           hereof the reporting person has ceased to be the beneficial owner of more
                           than five percent of the class of securities, check the following [ ].
 
         Item 6.  Ownership of More than Five Percent on Behalf of Another Person
 
                           The clients of the Investment Management Subsidiaries, including investment
                           companies registered under the Investment Company Act of 1940 and other
                           managed accounts, have the right to receive or power to direct the receipt of
                           dividends from, and the proceeds from the sale of, the securities reported
                           herein.   
 
              Franklin Biotechnology Discovery Fund, a series of Franklin Strategic Series, an
              investment company registered under the Investment Company Act of 1940, has an
              interest in 2,373,777 shares or 5.7% of the class of securities reported herein,
              and Franklin Biotechnology Discovery Fund, a sub-fund of Franklin Templeton
              Investment Funds, a Luxembourg registered SICAV, has an interest in 3,703,102 , or
              8.9% of the class of securities reported herein.

         Item 7.  Identification and Classification of the Subsidiary Which Acquired the
                           Security Being Reported on By the Parent Holding Company
 
                           See Attached Exhibit C
 
         Item 8.  Identification and Classification of Members of the Group
 
                           Not Applicable
 
         Item 9.  Notice of Dissolution of Group
 
                           Not Applicable

   

     CUSIP NO. 31189P102                           13G                            Page 10 of 15
 
         Item 10.  Certification
 
         By signing below I certify that, to the best of my knowledge and belief, the
         securities referred to above were acquired and are held in the ordinary course of
         business and were not acquired and are not held for the purpose of or with the effect
         of changing or influencing the control of the issuer of the securities and were not
         acquired and are not held in connection with or as a participant in any transaction
         having that purpose or effect.

         This report shall not be construed as an admission by the persons filing the report
         that they are the beneficial owner of any securities covered by this report.
 
         Exhibits. 
                           Exhibit A Joint Filing Agreement
                           Exhibit B Limited Powers of Attorney for Section 13 Reporting Obligations
                           Exhibit C Item 7 Identification and Classification of Subsidiaries
 
                                                                                 SIGNATURE 
 
         After reasonable inquiry and to the best of my knowledge and belief, I certify that
         the information set forth in this statement is true, complete and correct.
 
         Dated:  February 9, 2017
 
         Franklin Resources, Inc.
 
         Charles B. Johnson
 
         Rupert H. Johnson, Jr.
 
         Franklin Advisers, Inc.
 
         By:     /s/MARIA GRAY
                         ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑ 
                        Maria Gray
                        Vice President and Secretary of Franklin Resources, Inc.
 
                        Attorney‑in‑Fact for Charles B. Johnson pursuant to Power of Attorney
                        attached to this Schedule 13G
 
                        Attorney‑in‑Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney
                        attached to this Schedule 13G
 
            Secretary of Franklin Advisers, Inc.

     Franklin Strategic Series on behalf of
                                                     Franklin Biotechnology Discovery Fund

     Franklin Templeton Investment Funds on behalf of
                         Franklin Biotechnology Discovery Fund
 
     By:     /s/LORI A. WEBER
                         ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑ 
                        Lori A. Weber
                        Vice President and Assistant Secretary of Franklin Strategic Series
       
            Attorney‑in‑Fact for Franklin Templeton Investment Funds pursuant to a
            Limited Power of Attorney attached to this Schedule 13G

   

     CUSIP NO. 31189P102                           13G                            Page 11 of 15
 
         EXHIBIT A
 
         JOINT FILING AGREEMENT
 
         In accordance with Rule 13d‑1(k) under the Securities Exchange Act of 1934, as
         amended, the undersigned hereby agree to the joint filing with each other of the
         attached statement on Schedule 13G and to all amendments to such statement and that
         such statement and all amendments to such statement are made on behalf of each of
         them. 
 
         IN WITNESS WHEREOF, the undersigned have executed this agreement on February 9, 2017.
 
         Franklin Resources, Inc.
 
         Charles B. Johnson
 
         Rupert H. Johnson, Jr.
 
         Franklin Advisers, Inc.
 
         By:     /s/MARIA GRAY
                         ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑ 
                        Maria Gray
                        Vice President and Secretary of Franklin Resources, Inc.
 
                        Attorney‑in‑Fact for Charles B. Johnson pursuant to Power of Attorney
                        attached to this Schedule 13G
 
                        Attorney‑in‑Fact for Rupert H. Johnson, Jr. pursuant to Power of Attorney
                        attached to this Schedule 13G
 
            Secretary of Franklin Advisers, Inc.

 
     Franklin Strategic Series on behalf of
                                                     Franklin Biotechnology Discovery Fund

     Franklin Templeton Investment Funds on behalf of
                         Franklin Biotechnology Discovery Fund
 
     By:     /s/LORI A. WEBER
                         ‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑‑ 
                        Lori A. Weber
                        Vice President and Assistant Secretary of Franklin Strategic Series
       
            Attorney‑in‑Fact for Franklin Templeton Investment Funds pursuant to a
            Limited Power of Attorney attached to this Schedule 13G

   

     CUSIP NO. 31189P102                           13G                            Page 12 of 15
 
         EXHIBIT B
                                                                      LIMITED POWER OF ATTORNEY
                                                                                            FOR 
                                                               SECTION 13 REPORTING OBLIGATIONS
 
                                 Know all by these presents, that the undersigned hereby makes, constitutes
         and appoints each of Robert Rosselot and Maria Gray, each acting individually, as the
         undersigned’s true and lawful attorney‑in‑fact, with full power and authority as
         hereinafter described on behalf of and in the name, place and stead of the undersigned
         to: 
 
         (1)         prepare, execute, acknowledge, deliver and file Schedules 13D and 13G
         (including any amendments thereto or any related documentation) with the United States
         Securities and Exchange Commission, any national securities exchanges and Franklin
         Resources, Inc., a Delaware corporation (the “Reporting Entity”), as considered
         necessary or advisable under Section 13 of the Securities Exchange Act of 1934 and the
         rules and regulations promulgated thereunder, as amended from time to time (the
         “Exchange Act”); and
 
         (2)         perform any and all other acts which in the discretion of such
         attorney‑in‑fact are necessary or desirable for and on behalf of the undersigned in
         connection with the foregoing.
 
                                 The undersigned acknowledges that:
 
         (1)         this Limited Power of Attorney authorizes, but does not require, each such
         attorney‑in‑fact to act in their discretion on information provided to such
         attorney‑in‑fact without independent verification of such information;
         (2)         any documents prepared and/or executed by either such attorney‑in‑fact on
         behalf of the undersigned pursuant to this Limited Power of Attorney will be in such
         form and will contain such information and disclosure as such attorney‑in‑fact, in his
         or her discretion, deems necessary or desirable;
         (3)         neither the Reporting Entity nor either of such attorneys‑in‑fact assumes
         (i) any liability for the undersigned’s responsibility to comply with the requirements
         of the Exchange Act or (ii) any liability of the undersigned for any failure to comply
         with such requirements; and
         (4)         this Limited Power of Attorney does not relieve the undersigned from
         responsibility for compliance with the undersigned’s obligations under the Exchange
         Act, including without limitation the reporting requirements under Section 13 of the
         Exchange Act.
                                 The undersigned hereby gives and grants each of the foregoing
         attorneys‑in‑fact full power and authority to do and perform all and every act and
         thing whatsoever requisite, necessary or appropriate to be done in and about the
         foregoing matters as fully to all intents and purposes as the undersigned might or
         could do if present, hereby ratifying all that each such attorney‑in‑fact of, for and
         on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this
         Limited Power of Attorney.
                                 This Limited Power of Attorney shall remain in full force and effect until
         revoked by the undersigned in a signed writing delivered to each such
         attorney‑in‑fact. 
 
         IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be
         executed as of this     30th     day of         April       , 2007
 
                                                                                                                             /s/Charles B. Johnson
                                                                                                                             Signature 
 
                                                                                                                             Charles B. Johnson
                                                                                                                             Print Name

   

     CUSIP NO. 31189P102                           13G                            Page 13 of 15
 
                                                                     LIMITED POWER OF ATTORNEY
                                                                                           FOR 
                                                              SECTION 13 REPORTING OBLIGATIONS
 
                                 Know all by these presents, that the undersigned hereby makes,
         constitutes and appoints each of Robert Rosselot and Maria Gray, each acting
         individually, as the undersigned’s true and lawful attorney‑in‑fact, with full power
         and authority as hereinafter described on behalf of and in the name, place and stead
         of the undersigned to:
 
         (1)         prepare, execute, acknowledge, deliver and file Schedules 13D and 13G
         (including any amendments thereto or any related documentation) with the United
         States Securities and Exchange Commission, any national securities exchanges and
         Franklin Resources, Inc., a Delaware corporation (the “Reporting Entity”), as
         considered necessary or advisable under Section 13 of the Securities Exchange Act of
         1934 and the rules and regulations promulgated thereunder, as amended from time to
         time (the “Exchange Act”); and
 
         (2)         perform any and all other acts which in the discretion of such
         attorney‑in‑fact are necessary or desirable for and on behalf of the undersigned in
         connection with the foregoing.
 
                                 The undersigned acknowledges that:
 
         (1)         this Limited Power of Attorney authorizes, but does not require, each
         such attorney‑in‑fact to act in their discretion on information provided to such
         attorney‑in‑fact without independent verification of such information;
         (2)         any documents prepared and/or executed by either such attorney‑in‑fact
         on behalf of the undersigned pursuant to this Limited Power of Attorney will be in
         such form and will contain such information and disclosure as such attorney‑in‑fact,
         in his or her discretion, deems necessary or desirable;
         (3)         neither the Reporting Entity nor either of such attorneys‑in‑fact
         assumes (i) any liability for the undersigned’s responsibility to comply with the
         requirements of the Exchange Act or (ii) any liability of the undersigned for any
         failure to comply with such requirements; and
         (4)         this Limited Power of Attorney does not relieve the undersigned from
         responsibility for compliance with the undersigned’s obligations under the Exchange
         Act, including without limitation the reporting requirements under Section 13 of the
         Exchange Act.
                                 The undersigned hereby gives and grants each of the foregoing
         attorneys‑in‑fact full power and authority to do and perform all and every act and
         thing whatsoever requisite, necessary or appropriate to be done in and about the
         foregoing matters as fully to all intents and purposes as the undersigned might or
         could do if present, hereby ratifying all that each such attorney‑in‑fact of, for and
         on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this
         Limited Power of Attorney.
                                 This Limited Power of Attorney shall remain in full force and effect
         until revoked by the undersigned in a signed writing delivered to each such
         attorney‑in‑fact. 
 
         IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be
         executed as of this         25th        day of     April        , 2007
 
                                                                                                                       /s/ Rupert H. Johnson, Jr.
                                                                                                                       Signature 
 
                                                                                                                       Rupert H. Johnson, Jr.
                                                                                                                       Print Name

   

         CUSIP NO. 31189P102                       13G                             Page 14 of 15
 
                                                    LIMITED POWER OF ATTORNEY
                                               FOR 
                                SECTION 13 REPORTING OBLIGATIONS

             Know all by these presents, that we Franklin Templeton Investment Funds (the
     “Issuer”). an entity organized and existing in the Grand Duchy of Luxembourg and
     having our registered office at 8A rue Albert Borschette, L-1246 Luxembourg, in the person
     of Gregory Johnson and Vijay Advani, Directors of the Issuer, hereby makes, constitutes
     and appoints each of Lori Weber and Kimberly Novotny, each acting individually as the
     undersigned’s true and lawful attorney-in-fact, with full power and authority as
     hereinafter described on behalf of and in the name, place and stead of the undersigned to:
 
     (1)   prepare, execute, acknowledge, deliver and file Schedules 13D and 13G (including
     any amendments thereto or any related documentation) with the United States Securities
     and Exchange Commission, any national securities exchanges and Franklin Resources, Inc.,
     a Delaware corporation (the “Reporting Entity”), as considered necessary or advisable
     under Section 13 of the Securities Exchange Act of 1934 and the rules and regulations
     promulgated thereunder, as amended from time to time (the “Exchange Act”); and
 
     (2)   perform any and all other acts which in the discretion of such attorney‑in‑fact
     are necessary or desirable for and on behalf of the undersigned in connection with the
     foregoing.
 
             The undersigned acknowledges that:
 
     (1) this Limited Power of Attorney authorizes, but does not require, each such
     attorney‑in‑fact to act in their discretion on information provided to such
     attorney‑in‑fact without independent verification of such information;
 
     (2) any documents prepared and/or executed by either such attorney‑in‑fact on behalf of
     the undersigned pursuant to this Limited Power of Attorney will be in such form and will
     contain such information and disclosure as such attorney‑in‑fact, in his or her
     discretion, deems necessary or desirable;
 
     (3) neither the Reporting Entity nor either of such attorneys‑in‑fact assumes (i) any
     liability for the undersigned’s responsibility to comply with the requirements of the
     Exchange Act or (ii) any liability of the undersigned for any failure to comply with such
     requirements; and
 
     (4) this Limited Power of Attorney does not relieve the undersigned from responsibility
     for compliance with the undersigned’s obligations under the Exchange Act, including
     without limitation the reporting requirements under Section 13 of the Exchange Act.

     The undersigned hereby gives and grants each of the foregoing attorneys-in-fact full
     power and authority to do and perform all and every act and thing whatsoever requisite,
     necessary or appropriate to be done in and about the foregoing matters as fully to all
     intents and purposes as the undersigned might or could do if present, hereby ratifying
     all that each such attorney‑in‑fact of, for and on behalf of the undersigned, shall
     lawfully do or cause to be done by virtue of this Limited Power of Attorney.
 
     This Limited Power of Attorney shall remain in full force and effect until revoked by
     the undersigned in a signed writing delivered to each such attorney‑in‑fact.
 
     IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be
     executed as of this    13th     day of     October  , 2015.
 
                                                                       For and on behalf of
                                                        Franklin Templeton Investment Funds
 
                                                                         /s/Gregory Johnson
                                                                                   Director
 
                                                                            /s/Vijay Advani
                                                                                   Director

   

CUSIP NO.    31189P102                           13G                            Page 15 of 15
 
         EXHIBIT C
 
         Franklin Advisers, Inc.                                     Item 3 Classification: 3(e)